UnitedHealth investors have another bitter pill to swallow, as the CMS said it was aggressively growing its audit team to suss out “fraud, waste and abuse.”

UnitedHealth has dropped nearly 50% amid headwinds, but strong fundamentals, margin stability, and low valuation signal upside. See why UNH stock is a buy.

Key Takeaways UnitedHealth Group shares slid in recent trading Thursday after tumbling Wednesday amid worries about potential cuts to Medicaid and Medicare, and a report accusing the company of paying secret bonuses to nursing homes,

UnitedHealth has gone from bad to worse, and its drop is impacting the Dow Jones Industrial Average even more than it is the S&P 500.

UnitedHealth is again being accused of improper business practices for allegedly paying nursing homes to avert resident hospital transfers.

Stephen Hemsley never fully dropped the reins when he stepped down as UnitedHealth Group Inc.’s chief executive officer eight years ago. With the health giant in crisis, he’s taking back his old job – and confronting one of the toughest turnaround tasks any executive has ever faced.

The company has said in regulatory filings that investigations, audits and reviews by a dozen different government agencies are currently underway.

UnitedHealth insiders scooped up shares after the insurer’s stock swooned to a five-year low last week amid mounting federal fraud investigations and a sudden leadership change.

When CFRA’s Paige Meyer slapped a “sell” rating on UnitedHealth Group Inc. in February, she was the lone analyst out of 30 tracked by Bloomberg with a negative view of the company.

UnitedHealth Group shares were falling Wednesday after a downgrade from analysts at HSBC following the departure of the company’s CEO earlier this month. Shares in the group were down 4.1% and changing hands at $308.